C

GDTC

CytoMed Therapeutics Ltd

2.38

-0.03-1.24%
Closed15:33 04/29 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Total Revenue

0

0

0

0

0

Revenue

0

0

0

0

0

Other Revenue, Total

--

--

--

--

--

Cost of Revenue, Total

--

--

--

--

--

Gross Profit

--

--

--

--

--

Operating Expense

4.13M

3.13M

2.05M

1.94M

850.76K

Selling/General/Admin.Expenses,Total

2.65M

676.50K

661.46K

247.18K

159.68K

Research & Development

1.31M

1.24M

861.98K

832.19K

591.55K

Depreciation/Amortization

381.15K

392.87K

329.88K

292.53K

50.67K

Interest Exp.(Inc.), Net-Operating, Total

190.92K

183.05K

336.39K

105.95K

34.88K

Unusual Expense (Income)

0

-3.38K

-7.39K

-19.69K

0

Other Operating Expenses, Total

-405.24K

639.13K

-130.41K

477.46K

13.99K

Operating Income

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Interest Inc.(Exp.),Net-Non-Op.,Total

--

--

--

--

--

Gain(Loss) on Sale of Assets

--

--

--

--

--

Other, Net

--

--

--

--

--

Net Income Before Taxes

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Provision for Income Taxes

650

1.64K

0

0

0

Net Income After Taxes

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Minority Interest

-270

-240

-250

-190

0

Equity in Affiliates

--

--

--

--

--

U.S. GAAP Adjustment

--

--

--

--

--

Net Income Before Extra. Items

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Total Extraordinary Items

--

--

--

--

--

Net Income

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Total Adjustments to Net Income

--

--

--

--

--

Income Available to Com Excl ExtraOrd

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Income Available to Com Incl ExtraOrd

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Dilution Adjustment

--

--

--

--

--

Diluted Net Income

-4.13M

-3.13M

-2.05M

-1.94M

-850.76K

Diluted Weighted Average Shares

10.63M

11.53M

10.94M

10.94M

10.94M

Diluted EPS Excluding ExtraOrd Items

-0.38878

-0.27159

-0.18754

-0.17692

-0.07777

Diluted EPS including ExtraOrd Items

-0.388783

-0.271586

-0.18754

-0.176917

-0.077767

DPS – Common Stock Primary Issue

--

--

0

0

0

Diluted Normalized EPS

-0.38878

-0.27178

-0.18821

-0.17872

-0.07777